medigraphic.com
ISSN 2007-8560 (Print)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2024, Number 3

<< Back Next >>

Ortho-tips 2024; 20 (3)

Neurogenic myositis ossificans of the iliac muscle: a case report

Medina-Gómez LF, Aldana-Cetina AJ, Juárez-Oseguera A

Language: Spanish
References: 20
Page: 174-179
PDF size: 184.77 Kb.


ABSTRACT

Introduction: myositis ossificans is a type of heterotopic ossification that mainly involves muscle tissue. Heterotopic ossification is a pathological process, which consists of the formation of extraskeletal bone tissue, it occurs in certain situations such as trauma or neurological injuries, which in some cases limits the mobility of the involved body segment. The objective of this article is to present the case of a patient with myositis ossificans in the right iliac muscle secondary to a spinal cord injury. Case presentation: 23-year-old male with sequelae of a non-recent spinal cord injury secondary to a C6 fracture, who presented myositis ossificans of the iliac muscle, generating incapacity for passive mobility of the right hip, which made it difficult for his caregivers his hygiene and mobilization. He was successfully treated with an osteotomy and excision of the aberrant bone tissue. After six months of follow-up, the patient presents complete passive ranges of hip mobility and no radiographic evidence of recurrence. Conclusions: neurogenic myositis ossificans can limit the patient's quality of life. It is important to know the prophylactic options for cases in the initial stages as well as therapeutic options for advanced cases.


REFERENCES

  1. Xu Y, Huang M, He W, He C, Chen K, Hou J, et al. Heterotopic ossification: Clinical features, basic researches, and mechanical stimulations. Front Cell Dev Biol. 2022; 10: 770931. doi: 10.3389/fcell.2022.770931.

  2. Meyers C, Lisiecki J, Miller S, Levin A, Fayad L, Ding C, et al. Heterotopic ossification: A comprehensive review. JBMR Plus. 2019; 3 (4): e10172. doi: 10.1002/jbm4.10172.

  3. Behery OA, Dai AZ, McLaurin TM. Posttraumatic heterotopic ossification of the hip. J Orthop Trauma. 2018; 32 (4): S18-19.

  4. Saad A, Azzopardi C, Patel A, Davies AM, Botchu R. Myositis ossificans revisited - The largest reported case series. J Clin Orthop Trauma. 2021; 17: 123-127.

  5. Sankar R, Gowrishankar K, Viswanathan S. Genetic disorders with heterotopic ossificans. Indian J Orthop. 2015; 49 (3): 361-364. doi: 10.4103/0019-5413.156228.

  6. Cappato S, Gamberale R, Bocciardi R, Brunelli S. Genetic and acquired heterotopic ossification: A translational tale of mice and men. Biomedicines. 2020; 8 (12): 611. doi: 10.3390/biomedicines8120611.

  7. Dey D, Wheatley BM, Cholok D, Agarwal S, Yu PB, Levi B, et al. The traumatic bone: trauma-induced heterotopic ossification. Transl Res. 2017; 186: 95-111. doi: 10.1016/j.trsl.2017.06.004.

  8. Gugala Z, Olmsted-Davis EA, Xiong Y, Davis EL, Davis AR. Trauma-induced heterotopic ossification regulates the blood-nerve barrier. Front Neurol. 2018; 9: 408. doi: 10.3389/fneur.2018.00408.

  9. Domínguez Gasca LG, Magaña Reyes J, Domínguez Carrillo LG. Calcificación heterotópica de músculos pelvitrocantéreos secundaria a prótesis de cadera. Acta Med Grupo Ángeles. 2018; 16 (2): 164-165.

  10. Tlaite O, Kaoutar I, Soufiane R, Nabil MB, Ittimad N. Neurogenic myositis ossificans of the hip in a patient with axonal polyneuropathy. Galician Med J. 2022; 29 (4): e202248. doi: doi.org/10.21802/gmj.2022.4.8. Available from: https://ifnmujournal.com/gmj/article/view/E202248

  11. Law-ye B, Hangard C, Felter A, Safa D, Denormandie P, Genet F, et al. Pre-surgical CT-assessment of neurogenic myositis ossificans of the hip and risk factors of recurrence: a series of 101 consecutive patients. BMC Musculoskelet Disord. 2016; 17 (1): 433. doi: 10.1186/s12891-016-1294-2.

  12. Kim SW, Choi JH. Myositis ossificans in psoas muscle after lumbar spine fracture. Spine (Phila Pa 1976). 2009; 34 (10): E367-370.

  13. Yoon B-H, Park IK, Sung Y-B. Ankylosing neurogenic myositis ossificans of the hip: A case series and review of literature. Hip Pelvis. 2018; 30 (2): 86. doi: 10.5371/hp.2018.30.2.86.

  14. Hammad Y, Akiely R, Hajjaj N, Tahboub F, Al-Ajlouni J. The surgical management of the rare neurogenic myositis ossificans of the hip: A report of 3 cases. J Orthop Case Rep. 2021; 11 (3): 45. doi: 10.13107/jocr.2021.v11.i03.2082.

  15. Vanden Bossche L, Vanderstraeten G. Heterotopic ossification: A review. J Rehabil Med. 2005; 37 (3): 129-136. doi: 10.1080/16501970510027628.

  16. Choi KH, Park S-G, Baek JH, Lee W, Chang MC. Myositis ossificans causing ulnar neuropathy: a case report. J Int Med Res. 2021; 49 (3): 030006052110026.

  17. Schneider J, Maffulli N, Eschweiler J, Bell A, Hildebrand F, Migliorini F. Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study. Sci Rep. 2023; 13 (1): 1-8.

  18. Georhakopoulos I, Kouloulias V, Kougiountzopoulou A, Platoni K, Antypas C, Liakouli Z, et al. Radiation therapy for the prevention of heterotopic ossification: Efficacy and toxicity of single fraction radiotherapy. Orthop Rev (Pavia). 2020; 12 (2): 8577. doi: 10.4081/or.2020.8577.

  19. Ruo Redda MG, De Colle C, Bianco L, Ruggieri A, Nassisi D, Rossi A, et al. Heterotopic ossifications: role of radiotherapy as prophylactic treatment. Radiol Med. 2018; 123 (6): 463-468.

  20. Shapira J, Yelton MJ, Chen JW, Rosinsky PJ, Maldonado DR, Meghpara M, et al. Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis. Hip Int. 2022; 32 (5): 576-590.




2020     |     www.medigraphic.com